Molecure SA
WSE:MOC
Intrinsic Value
The intrinsic value of one MOC stock under the Base Case scenario is 4.34 PLN. Compared to the current market price of 8.3 PLN, Molecure SA is Overvalued by 48%.
The Intrinsic Value is calculated as the average of DCF and Relative values:
Valuation History
Molecure SA
Fundamental Analysis

Revenue & Expenses Breakdown
Molecure SA
Balance Sheet Decomposition
Molecure SA
Current Assets | 54.5m |
Cash & Short-Term Investments | 52.4m |
Receivables | 637.4k |
Other Current Assets | 1.5m |
Non-Current Assets | 54.3m |
PP&E | 9.9m |
Intangibles | 44.4m |
Free Cash Flow Analysis
Molecure SA
PLN | |
Free Cash Flow | PLN |
Earnings Waterfall
Molecure SA
Revenue
|
360.2k
PLN
|
Cost of Revenue
|
-2m
PLN
|
Gross Profit
|
-1.6m
PLN
|
Operating Expenses
|
-23.3m
PLN
|
Operating Income
|
-24.9m
PLN
|
Other Expenses
|
3m
PLN
|
Net Income
|
-21.9m
PLN
|
MOC Profitability Score
Profitability Due Diligence
Molecure SA's profitability score is 17/100. The higher the profitability score, the more profitable the company is.
Score
Molecure SA's profitability score is 17/100. The higher the profitability score, the more profitable the company is.
MOC Solvency Score
Solvency Due Diligence
Molecure SA's solvency score is 87/100. The higher the solvency score, the more solvent the company is.
Score
Molecure SA's solvency score is 87/100. The higher the solvency score, the more solvent the company is.
Wall St
Price Targets
MOC Price Targets Summary
Molecure SA
According to Wall Street analysts, the average 1-year price target for MOC is 18.62 PLN with a low forecast of 16.67 PLN and a high forecast of 21 PLN.
Dividends
Current shareholder yield for MOC is .
Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?
The intrinsic value of one MOC stock under the Base Case scenario is 4.34 PLN.
Compared to the current market price of 8.3 PLN, Molecure SA is Overvalued by 48%.